ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Institut Jules Bordet, Brussels (Bruxelles)

Institut Claudius Regaud, Toulouse

CRLCC Nantes - Atlantique, Nantes-Saint Herblain

Centre Jean Perrin, Clermont-Ferrand

Centre Leon Berard, Lyon

Universitaetsklinik, Innsbruck

Kaiser Franz Josef Hospital, Vienna (Wien)

Ludwig Institute for Cancer Research-Brussels Branch, Brussels (Bruxelles)

Universitair Ziekenhuis Antwerpen, Edegem

U.Z. Gasthuisberg, Leuven

Herlev Hospital - University Hospital of Copenhagen, Herlev

Institut Gustave Roussy, Villejuif

Universitaetsklinik und Strahlenklinik - Essen, Essen

Klinikum Nurnberg, Nuremberg (Nurnberg)

Academisch Ziekenhuis der Vrije Universiteit, Amsterdam

Antoni van Leeuwenhoekhuis, Amsterdam

Academisch Ziekenhuis Groningen, Groningen

St. Radboud University Hospital, Nijmegen

Rotterdam Cancer Institute, Rotterdam

Norwegian Radium Hospital, Oslo

University Hospital, Basel

Inselspital, Bern, Bern

Kantonsspital - Saint Gallen, Sankt Gallen

Newcastle General Hospital, Newcastle upon Tyne

Ninewells Hospital and Medical School, Dundee

Western General Hospital, Edinburgh

C.R.C. Beatson Laboratories, Glasgow